Ratings Adcock Ingram Holdings Limited

Equities

AIP

ZAE000123436

End-of-day quote Johannesburg S.E. Other stock markets 03:30:00 07/06/2024 am IST			5-day change	1st Jan Change
55.17 ^ZAR	+2.45%		-2.84%	-8.20%

21/02	Adcock Ingram Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI
21/02	Transcript : Adcock Ingram Holdings Limited, H1 2024 Earnings Call, Feb 21, 2024

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

With regards to fundamentals, the enterprise value to sales ratio is at 0.89 for the current period. Therefore, the company is undervalued.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Pharmaceuticals

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
ADCOCK INGRAM HOLDINGS LIMITED	-8.20%	431M		B
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.64%	43.3B		B-
OTSUKA HOLDINGS CO., LTD.	+21.25%	22.22B		B+
SANDOZ GROUP AG	+18.92%	15.43B		-
CIPLA LIMITED	+20.14%	14.48B		B+
ZYDUS LIFESCIENCES LIMITED	+53.19%	12.72B		B
THE MEDICINES COMPANY	-0.05%	6.79B	-	-
ONO PHARMACEUTICAL CO., LTD.	-11.11%	6.71B		B+
STADA ARZNEIMITTEL	-8.87%	5.73B	-	-
ASPEN PHARMACARE HOLDINGS LIMITED	+14.68%	5.5B		B+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes